Immunopathology and Immunotherapy for Breast Cancer
- 13 December 2020
- book chapter
- Published by Springer Nature
- p. 541-555
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancersNature Genetics, 2013
- Transcriptome analysis using next-generation sequencingCurrent Opinion in Biotechnology, 2013
- Mesenchymal stem cells engineered for cancer therapyAdvanced Drug Delivery Reviews, 2012
- Mutational Processes Molding the Genomes of 21 Breast CancersCell, 2012
- The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroupsNature, 2012
- Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast CancerNew England Journal of Medicine, 2012
- Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trialThe Lancet Oncology, 2012
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid LeukemiaNew England Journal of Medicine, 2011
- Improved Survival with Ipilimumab in Patients with Metastatic MelanomaNew England Journal of Medicine, 2010
- Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2Molecular Therapy, 2010